Our Corporate Values
Strive for Good Science and Strong Processes
MMS is committed to making sound decisions based on strong scientific principles, internal expertise, and applicable regulation. As an organization, MMS emphasizes and values strong internal processes through defining, following, and improving upon the steps that lead to high-quality deliverables.
Value Talent – Find, Attract, Enhance and Retain
MMS recognizes that a talented staff is what drives our business forward. Identifying and attracting top talent and continual training to strengthen core skills are essential to core mission. At MMS, enthusiasm, collaboration, and teamwork is fostered, knowing that a global and diverse talent pool makes the company stronger.
Wow the Customer
MMS believes in delivering value beyond the competition. Each sponsor and researcher that MMS partners with is important and their goals relevant. MMS will strive to exceed their expectations by maintaining a customer focus throughout the project lifecycle, ensuring the customer experience is positive, building trust and forging long-term relationships.
Bring a Sense of Urgency and Leadership (SOUL)
MMS promotes the importance of SOUL through a healthy work environment and as a requirement for providing added value to clients. The SOUL of MMS comes to life as project work is completed on time and as risks and solutions are identified proactively. At MMS, each colleague takes responsibility for the success of every project.
“MMS does a great job of supporting colleague development through extensive training, job shadowing, mentoring, and teamwork activities.”
Suggested For You
perspectives
October 8th, 2024
Diversity Action Plan Guidance Part I: Implications for Sponsors
webinar
October 22nd, 2024
Optimal Strategies to Protect Commercially Confidential Information (CCI) in Clinical Documents and Report Trial Results Under Revised EU-CTIS Transparency Rules
perspectives
September 30th, 2024
Meet the Leaders Driving MMS’s European Growth
perspectives
September 30th, 2024
The Future of Data Management and Biostatistics: Trends and Technologies Shaping the Industry
perspectives
September 24th, 2024
Embracing Quality Management Maturity (QMM) at the Cornerstone of the Pharmaceutical Industry
perspectives
September 11th, 2024
From Historical Precedent to Modern Approvals: Lessons Learned on OTC Drug Products for FDA OMORs
webinar
September 26th, 2024
Regulatory Pathways for Nonprescription Drugs: A Deep Dive into OTC Monograph Reform and FDA Guidance
perspectives
September 4th, 2024
Email Security – Navigating Through the Process of Validation and Compliance with Healthcare Business Stakeholders
perspectives
August 27th, 2024
Optimizing Oncology Drug Development: FDA Expedited Pathways, Real-Time Review, and Global Programs
regulatory intelligence
August 27th, 2024
Recent Guidance on Diversity Action Planning
regulatory intelligence
August 26th, 2024
Oncology Programs at the FDA
regulatory intelligence
August 26th, 2024
Three Key Take Reflections on the Recent Donanemab Approval